HOFFMANN; Torsten
Patent Applications and Registrations
Patent applications and USPTO patent grants for HOFFMANN; Torsten.The latest application filed is for "novel inhibitors".
Company Profile
1.76.86
- HOFFMANN; Torsten - Halle Saale
- Hoffmann; Torsten - Halle DE
- Hoffmann; Torsten - Wil am Rhein DE
- Hoffmann; Torsten - Weil am Rhein DE
- Hoffmann; Torsten - Radebeul DE
- Hoffmann; Torsten - Haale/Saale DE
- Hoffmann; Torsten - Haale DE
- Hoffmann; Torsten - US
- Hoffmann; Torsten - D-06114 Halle/Saale DE
- Hoffmann; Torsten - Birsfelden CH
- Hoffmann; Torsten - Lorrach DE
- Hoffmann, Torsten - Koernerstrasse DE
- Hoffmann, Torsten - Halle/Salle DE
- Hoffmann, Torsten - Kornerstr DE
- Hoffmann; Torsten - Dresden DE
Patent Activity
| Patent | Date |
|---|---|
| Novel Inhibitors App 20220274977 - HEISER; Ulrich ; et al. | 2022-09-01 |
| Inhibitors Grant 11,339,152 - Heiser , et al. May 24, 2 | 2022-05-24 |
| Novel Inhibitors App 20200377493 - HEISER; Ulrich ; et al. | 2020-12-03 |
| Small molecule conjugates for intracellular delivery of biologically active compounds Grant 9,968,647 - Hadwiger , et al. May 15, 2 | 2018-05-15 |
| Novel Method for the Detection of pGlu-Abeta Peptides App 20170363645 - Kleinschmidt; Martin ; et al. | 2017-12-21 |
| Galactose cluster-pharmacokinetic modulator targeting moiety for siRNA Grant 9,796,756 - Hadwiger , et al. October 24, 2 | 2017-10-24 |
| Inhibitors Grant 9,650,362 - Heiser , et al. May 16, 2 | 2017-05-16 |
| Small Molecule Conjugates For Intracellular Delivery Of Biologically Active Compounds App 20170022505 - Hadwiger; Philipp ; et al. | 2017-01-26 |
| Mouse carrying a knock-out mutation of the Qpct-gene Grant 9,462,793 - Schilling , et al. October 11, 2 | 2016-10-11 |
| Galactose Cluster-Pharmacokinetic Modulator Targeting Moiety for siRNA App 20160102120 - Hadwiger; Philipp ; et al. | 2016-04-14 |
| Small molecule conjugates for intracellular delivery of biologically active compounds Grant 9,301,990 - Hadwiger , et al. April 5, 2 | 2016-04-05 |
| Novel Inhibitors App 20160039795 - Heiser; Ulrich ; et al. | 2016-02-11 |
| Galactose cluster-pharmacokinetic modulator targeting moiety for siRNA Grant 9,249,179 - Hadwiger , et al. February 2, 2 | 2016-02-02 |
| Small molecule conjugates for intracellular delivery of nucleic acids Grant 9,198,947 - Hadwiger , et al. December 1, 2 | 2015-12-01 |
| Inhibitors of glutaminyl cyclase Grant 9,181,233 - Heiser , et al. November 10, 2 | 2015-11-10 |
| Inhibitors Grant 9,173,885 - Heiser , et al. November 3, 2 | 2015-11-03 |
| Peptide-based in vivo siRNA delivery system Grant 9,107,957 - Rozema , et al. August 18, 2 | 2015-08-18 |
| Compositions for targeted delivery of siRNA Grant 9,011,919 - Rozema , et al. April 21, 2 | 2015-04-21 |
| Pharmaceutical Formulations App 20150072006 - Moschner; Katrin ; et al. | 2015-03-12 |
| Use of isoQC inhibitors in the treatment and prevention of inflammatory diseases or conditions Grant 8,889,709 - Demuth , et al. November 18, 2 | 2014-11-18 |
| Method for prophylactic treatment of alzheimer's disease using inhibitors of glutaminyl cyclase and glutamate cyclases Grant 8,809,010 - Hoffmann , et al. August 19, 2 | 2014-08-19 |
| In vivo polynucleotide delivery conjugates having enzyme sensitive linkages Grant 8,802,773 - Rozema , et al. August 12, 2 | 2014-08-12 |
| Small molecule conjugates for intracellular delivery of biologically active compounds App 20140135381 - Hadwiger; Philipp ; et al. | 2014-05-15 |
| Small molecule conjugates for intracellular delivery of nucleic acids App 20140135380 - Hadwiger; Philipp ; et al. | 2014-05-15 |
| Use of inhibtors of glutaminyl cyclases for treatment and prevention of disease Grant 8,685,664 - Demuth , et al. April 1, 2 | 2014-04-01 |
| Novel Inhibitors App 20140065095 - Heiser; Ulrich ; et al. | 2014-03-06 |
| Peptide-Based In Vivo siRNA Delivery System App 20130281658 - Rozema; David B ; et al. | 2013-10-24 |
| Inhibitors Grant 8,541,596 - Heiser , et al. September 24, 2 | 2013-09-24 |
| Compositions for Targeted Delivery of siRNA App 20130245091 - Rozema; David B. ; et al. | 2013-09-19 |
| Peptide-based in vivo siRNA delivery system Grant 8,501,930 - Rozema , et al. August 6, 2 | 2013-08-06 |
| In Vivo Polynucleotide Delivery Conjugates Having Enzyme Sensitive Linkages App 20130190484 - Rozema; David ; et al. | 2013-07-25 |
| Inhibitors Grant 8,486,940 - Heiser , et al. July 16, 2 | 2013-07-16 |
| Use of effectors of glutaminyl and glutamate cyclases Grant 8,470,781 - Schilling , et al. June 25, 2 | 2013-06-25 |
| In vivo polynucleotide delivery conjugates having enzyme sensitive linkages Grant 8,426,554 - Rozema , et al. April 23, 2 | 2013-04-23 |
| N-pyridin-3-yl or N-pyrazin-2-yl carboxamides Grant 8,410,107 - Grether , et al. April 2, 2 | 2013-04-02 |
| Dual NK1/NK3 receptor antagonists Grant 8,404,708 - Hoffmann , et al. March 26, 2 | 2013-03-26 |
| In Vivo Screening Models For Treatment Of Qc-related Disorders App 20130052203 - Graubner; Sigrid ; et al. | 2013-02-28 |
| Combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases Grant 8,268,864 - Fyrnys , et al. September 18, 2 | 2012-09-18 |
| Inhibitors of glutaminyl cyclase Grant 8,227,498 - Buchholz , et al. July 24, 2 | 2012-07-24 |
| In Vivo Polynucleotide Delivery Conjugates Having Enzyme Sensitive Linkages App 20120172412 - Rozema; David B. ; et al. | 2012-07-05 |
| GALACTOSE CLUSTER-PHARMACOKINETIC MODULATOR TARGETING MOIETY FOR siRNA App 20120157509 - Hadwiger; Philipp ; et al. | 2012-06-21 |
| Compounds Grant 8,178,583 - Hoffmann , et al. May 15, 2 | 2012-05-15 |
| N-pyridin-3-yl Or N-pyrazin-2-yl Carboxamides App 20120094993 - Grether; Uwe ; et al. | 2012-04-19 |
| Novel Inhibitors App 20110262388 - Heiser; Ulrich ; et al. | 2011-10-27 |
| Novel Inhibitors App 20110224259 - HEISER; Ulrich ; et al. | 2011-09-15 |
| Compositions for Targeted Delivery of siRNA App 20110207799 - Rozema; David B. ; et al. | 2011-08-25 |
| Dual Nk1/nk3 Receptor Antagonists App 20110178055 - Hoffmann; Torsten ; et al. | 2011-07-21 |
| Dual NK1/NK3 receptor antagonists Grant 7,939,533 - Hoffmann , et al. May 10, 2 | 2011-05-10 |
| Novel Inhibitors App 20110092501 - Heiser; Ulrich ; et al. | 2011-04-21 |
| Method Of Treatment And/or Prevention Of Brain, Spinal Or Nerve Injury App 20110053954 - Hoffmann; Torsten ; et al. | 2011-03-03 |
| Pyrrolidine derivatives as dual NK1/NK3 receptor antagonists Grant 7,893,062 - Bissantz , et al. February 22, 2 | 2011-02-22 |
| Secondary binding site of dipeptidyl peptidase IV (DP IV) Grant 7,816,325 - Kuhn-Wache , et al. October 19, 2 | 2010-10-19 |
| Novel Compounds App 20100160441 - Hoffmann; Torsten ; et al. | 2010-06-24 |
| Use Of Isoqc Inhibitors App 20100125086 - Demuth; Hans-Ulrich ; et al. | 2010-05-20 |
| Use Of Inhibitors Of Glutaminyl Cyclase And Glutamate Cyclase For Treatment And Prevention Of Neurodegenerative Diseases App 20100040575 - Hoffmann; Torsten ; et al. | 2010-02-18 |
| Peptidyl ketones as inhibitors of DPIV Grant 7,608,577 - Heiser , et al. October 27, 2 | 2009-10-27 |
| Mouse Models Carrying A Knock-out Mutation Of The Qpct-gene App 20090183267 - Schilling; Stephan ; et al. | 2009-07-16 |
| Use Of Effectors Of Glutaminyl And Glutamate Cyclases App 20090149394 - Schilling; Stephan ; et al. | 2009-06-11 |
| Dual Nk1/nk3 Receptor Antagonists App 20090137806 - Hoffmann; Torsten ; et al. | 2009-05-28 |
| Use Of Glutaminyl Cyclase Inhibitors App 20090068699 - Schilling; Stephan ; et al. | 2009-03-12 |
| Use of effectors of glutaminyl and glutamate cyclases Grant 7,462,599 - Schilling , et al. December 9, 2 | 2008-12-09 |
| Use of Inhibtors of Glutaminyl Cyclases for Treatment and Prevention of Disease App 20080286810 - Demuth; Hans-Ulrich ; et al. | 2008-11-20 |
| Pyrrolidine Derivatives As Dual Nk1/nk3 Receptor Antagonists App 20080275021 - Bissantz; Caterina ; et al. | 2008-11-06 |
| Novel Inhibitors Of Glutaminyl Cyclase App 20080267912 - Buchholz; Mirko ; et al. | 2008-10-30 |
| In Vivo Screening Models For Treatment Of Alzheimer's Disease And Other Qpct-related Disorders App 20080200567 - Schilling; Stephan ; et al. | 2008-08-21 |
| Use of inhibitors of glutaminyl cyclases for treatment and prevention of disease Grant 7,381,537 - Demuth , et al. June 3, 2 | 2008-06-03 |
| Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis Grant 7,368,421 - Demuth , et al. May 6, 2 | 2008-05-06 |
| Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents Grant 7,368,576 - von Hoersten , et al. May 6, 2 | 2008-05-06 |
| Effectors of dipeptidyl peptidase IV for topical use Grant 7,335,645 - Demuth , et al. February 26, 2 | 2008-02-26 |
| Use Of Effectors Of Glutaminyl And Glutamate Cyclases App 20070191366 - Hoffmann; Torsten ; et al. | 2007-08-16 |
| Serotonin transporter (SERT) inhibitors for the treatment of depression and anxiety App 20070129419 - Grundschober; Christophe ; et al. | 2007-06-07 |
| NK-1 receptor antagonists Grant 7,211,579 - Funk , et al. May 1, 2 | 2007-05-01 |
| Bi-pyridinyl derivatives as NK-1 antagonists Grant 7,176,205 - Hoffmann , et al. February 13, 2 | 2007-02-13 |
| Prodrugs of DP IV-inhibitors Grant 7,166,579 - Demuth , et al. January 23, 2 | 2007-01-23 |
| Crystalline modifications of 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1,1-dioxo-1 .lamda..sup.6-thiomorpholin-4-yl)-4-(4-fluoro-2-methyl-phenyl)-pyridin-3-- yl]-N-methyl-isobutyramide Grant 7,160,881 - Hoffmann , et al. January 9, 2 | 2007-01-09 |
| Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents App 20060293248 - von Hoersten; Stephen ; et al. | 2006-12-28 |
| Method of treatment and/or prevention of brain, spinal or nerve injury App 20060247240 - Hoffmann; Torsten ; et al. | 2006-11-02 |
| NK-1 receptor antagonists App 20060217393 - Funk; Christoph ; et al. | 2006-09-28 |
| Combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases App 20060211729 - Fyrnys; Beatrix ; et al. | 2006-09-21 |
| Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents Grant 7,109,347 - von Hoersten , et al. September 19, 2 | 2006-09-19 |
| Glutaminyl based DPIV inhibitors App 20060194852 - Demuth; Hans-Ulrich ; et al. | 2006-08-31 |
| Bi-pyridinyl derivatives as NK-1 antagonists App 20060189626 - Hoffmann; Torsten ; et al. | 2006-08-24 |
| Use of effectors of glutaminyl and glutamate cyclases App 20060189523 - Schilling; Stephan ; et al. | 2006-08-24 |
| Prodrugs of DP IV-inhibitors Grant 7,084,120 - Demuth , et al. August 1, 2 | 2006-08-01 |
| Glutaminyl based DPIV inhibitors Grant 7,060,719 - Demuth , et al. June 13, 2 | 2006-06-13 |
| Compounds of unstable DP IV-inhibitors Grant 7,053,055 - Demuth , et al. May 30, 2 | 2006-05-30 |
| Pharmaceutical Formulations and Method for Making App 20060029670 - Hoffmann; Torsten ; et al. | 2006-02-09 |
| Treatment of rhinitis with anticholinergics alone or in combination with antihistamines, phosphodiesterase 4 inhibitors, or corticosteroids App 20050222102 - Maus, Joachim ; et al. | 2005-10-06 |
| Effectors of dipeptidyl peptidase IV for topical use Grant 6,949,515 - Demuth , et al. September 27, 2 | 2005-09-27 |
| Effectors of dipeptidyl peptidase IV for topical use App 20050209159 - Demuth, Hans-Ulrich ; et al. | 2005-09-22 |
| Glutaminyl based DPIV inhibitors Grant 6,946,480 - Demuth , et al. September 20, 2 | 2005-09-20 |
| Secondary binding site of dipeptidyl peptidase IV (DPIV) App 20050176622 - Kuhn-Wache, Kerstin ; et al. | 2005-08-11 |
| Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents App 20050171025 - von Hoersten, Stephan ; et al. | 2005-08-04 |
| NK-1 receptor active amine oxide prodrugs Grant 6,897,226 - Hoffmann , et al. May 24, 2 | 2005-05-24 |
| Dual NK1/NK3 receptor antagonists App 20050090533 - Hoffmann, Torsten ; et al. | 2005-04-28 |
| Use of effectors of glutaminyl and glutamate cyclases App 20050058635 - Demuth, Hans-Ulrich ; et al. | 2005-03-17 |
| Aromatic and heteroaromatic substituted amides Grant 6,849,624 - Ballard , et al. February 1, 2 | 2005-02-01 |
| Substituted amino ketone compounds App 20050014946 - Demuth, Hans-Ulrich ; et al. | 2005-01-20 |
| Glutaminyl based DP IV-inhibitors App 20040229848 - Demuth, Hans-Ulrich ; et al. | 2004-11-18 |
| Crystalline modifications of 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1,1-- dioxo-1 lambda 6-thiomorpholin-4-yl)-4-(4-fluoro-2-methyl-phenyl)-pyridin-- 3-yl]-N-methyl-isobutyramide App 20040186100 - Hoffmann, Torsten ; et al. | 2004-09-23 |
| Prodrugs of DP IV-inhibitors App 20040171555 - Demuth, Hans-Ulrich ; et al. | 2004-09-02 |
| Glutaminyl based DPIV inhibitors App 20040167191 - Demuth, Hans-Ulrich ; et al. | 2004-08-26 |
| Substituted 4-phenyl-pyridine compounds with activity as antagonists of neurokinin 1 receptors Grant 6,770,637 - Godel , et al. August 3, 2 | 2004-08-03 |
| 5-phenyl-pyrimidine derivatives Grant 6,756,380 - Bos , et al. June 29, 2 | 2004-06-29 |
| NK-1 receptor active amine oxide prodrugs Grant 6,747,026 - Hoffmann , et al. June 8, 2 | 2004-06-08 |
| D-proline derivatives Grant 6,740,760 - Hertel , et al. May 25, 2 | 2004-05-25 |
| Secondary binding site of dipeptidyl peptidase IV (DP IV) App 20040058876 - Hoffmann, Torsten ; et al. | 2004-03-25 |
| NK-1 receptor active amine oxide prodrugs App 20040048901 - Hoffmann, Torsten ; et al. | 2004-03-11 |
| Method for the treatment of neurological and neuropsychological disorders App 20040043919 - Von Horsten, Stephan ; et al. | 2004-03-04 |
| NK-1 receptor active amine oxide prodrugs App 20040014793 - Hoffmann, Torsten ; et al. | 2004-01-22 |
| Heteroaromatic substituted amides with antagonistic activity to neurokinin 1 receptors Grant 6,624,176 - Hoffmann , et al. September 23, 2 | 2003-09-23 |
| Glutaminyl based DPIV inhibitors App 20030162820 - Demuth, Hans-Ulrich ; et al. | 2003-08-28 |
| Peptidyl ketones as inhibitors of DPIV App 20030148961 - Heiser, Ulrich ; et al. | 2003-08-07 |
| NK-1 receptor active amine oxide prodrugs App 20030149039 - Hoffmann, Torsten ; et al. | 2003-08-07 |
| Phenyl substituted pyridine and benzene derivatives Grant 6,596,773 - Bos , et al. July 22, 2 | 2003-07-22 |
| Peptide structures useful for competitive modulation of dipeptidyl peptidase IV catalysis App 20030135023 - Demuth, Hans-Ulrich ; et al. | 2003-07-17 |
| NK-1 receptor active amine oxide prodrugs Grant 6,593,472 - Hoffmann , et al. July 15, 2 | 2003-07-15 |
| Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents App 20030130199 - von Hoersten, Stephan ; et al. | 2003-07-10 |
| Heteroaromatic substituted amides with antagonistic activity to neurokinin 1 receptors App 20030130508 - Hoffmann, Torsten ; et al. | 2003-07-10 |
| Substituted amino ketone compounds App 20030125304 - Demuth, Hans-Ulrich ; et al. | 2003-07-03 |
| Use of dipeptidyl peptidase IV inhibitors App 20030119750 - Demuth, Hans-Ulrich ; et al. | 2003-06-26 |
| D-proline derivatives App 20030100770 - Hertel, Cornelia ; et al. | 2003-05-29 |
| New Effectors Of Dipeptidyl Peptidase Iv For Topical Use App 20030092630 - Demuth , Hans-Ulrich ; et al. | 2003-05-15 |
| Method of treatment and/or prevention of brain, spinal or nerve injury App 20030083345 - Hoffmann, Torsten ; et al. | 2003-05-01 |
| Aromatic and heteroaromatic substituted amides App 20030064983 - Ballard, Theresa Maria ; et al. | 2003-04-03 |
| Use of NK-1 receptor antagonists against benign prostatic hyperplasia App 20030004157 - Buser, Susanne ; et al. | 2003-01-02 |
| 4-phenyl-pyridine derivatives Grant 6,479,483 - Bos , et al. November 12, 2 | 2002-11-12 |
| New effectors of dipeptidyl peptidase IV for topical use App 20020165164 - Demuth, Hans-Ulrich ; et al. | 2002-11-07 |
| Phenyl substituted pyridine and benzene derivatives App 20020111367 - Bos, Michael ; et al. | 2002-08-15 |
| 4-phenyl-pyridine derivatives App 20020091265 - Bos, Michael ; et al. | 2002-07-11 |
| Phenyl substituted pyridine and benzene derivatives Grant 6,407,111 - Bos , et al. June 18, 2 | 2002-06-18 |
| Method for raising the blood glucose level in mammals App 20020071838 - Demuth, Hans-Ulrich ; et al. | 2002-06-13 |
| Prodrugs of DP IV-inhibitors App 20020049164 - Demuth, Hans-Ulrich ; et al. | 2002-04-25 |
| NK-1 receptor active amine oxide prodrugs App 20020045642 - Hoffmann, Torsten ; et al. | 2002-04-18 |
| Substituted 4-phenyl-pyridine compounds with activity as antagonists of neurokinin 1 receptors App 20020040040 - Godel, Thierry ; et al. | 2002-04-04 |
| Biphenyl derivatives App 20020040060 - Bos, Michael ; et al. | 2002-04-04 |
| Pharmaceutical formulations and method for making App 20020015730 - Hoffmann, Torsten ; et al. | 2002-02-07 |
| Substituted heterocyclic siprodecane compound active as an antagonist of neurokinin 1 receptor App 20020006932 - Galley, Guido ; et al. | 2002-01-17 |
| Raising blood sugar level in hypoglycemic mammals by administering inhibitors of dipeptidyl peptidase IV Grant 6,319,893 - Demuth , et al. November 20, 2 | 2001-11-20 |
| 4-phenyl-pyridine derivatives Grant 6,297,375 - Bos , et al. October 2, 2 | 2001-10-02 |
| Compounds of unstable DP IV-inhibitors App 20010020006 - Demuth, Hans-Ulrich ; et al. | 2001-09-06 |
| 4-phenyl-pyrimidine derivatives Grant 6,274,588 - Bos , et al. August 14, 2 | 2001-08-14 |
| 3-phenyl-pyridine-derivatives Grant 6,225,316 - Bos , et al. May 1, 2 | 2001-05-01 |
| Process for preparing a controlled release composition Grant 6,103,264 - Hoffmann , et al. August 15, 2 | 2000-08-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 